Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.
Men with BRCA1 and BRCA2 gene mutations should be given annual prostate cancer screening checks, leading scientists have said. Experts at the Institute of Cancer Research (ICR) in London said men with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback